Xometry, Inc. Announces Pricing and Details of \$225 Million Public Offering of Class A Common Stock
Xometry, Inc. (NASDAQ: XMTR) has announced the pricing and execution of a significant public offering of its Class A common stock, a move expected to raise approximately \$225 million, excluding any option shares for the underwriters. The company has entered into an underwriting agreement with several leading investment banks, which could have important implications for current and prospective investors.
Key Highlights of the Offering
- Size of the Offering: Xometry is offering 2,647,059 shares of its Class A common stock, par value \$0.000001 per share.
- Public Offering Price: The shares are being offered to the public at \$85.00 per share, a price point that reflects strong institutional demand and could signal management’s confidence in the company’s future prospects.
- Underwriters’ Option: The underwriters have a 30-day option to purchase up to an additional 397,058 shares at the public offering price, less underwriting discounts and commissions.
- Use of Proceeds: Xometry expects to use the net proceeds from the offering for general corporate purposes, including potential acquisitions, investments in technology, working capital, and other business purposes. The company’s stated flexibility in deploying this capital suggests a focus on growth and expansion.
- Underwriter Syndicate: The offering is being led by a syndicate of major investment banks, including J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, William Blair & Company, L.L.C., Citizens JPM Securities, LLC, Cantor Fitzgerald & Co., and Craig-Hallum Capital Group LLC. The allocation of shares is as follows:
- J.P. Morgan Securities LLC: 976,103 shares
- Goldman Sachs & Co. LLC: 976,103 shares
- William Blair & Company, L.L.C.: 248,162 shares
- Citizens JPM Securities, LLC: 198,529 shares
- Cantor Fitzgerald & Co.: 124,081 shares
- Craig-Hallum Capital Group LLC: 124,081 shares
Important Points for Shareholders
- Potential Stock Dilution: The issuance of new shares is expected to dilute existing shareholders. However, if the capital is effectively deployed for strategic growth or accretive acquisitions, this could enhance shareholder value over time.
- Lock-Up Period: The company and its directors and officers have agreed to a 45-day lock-up period following the offering, during which time they will not offer, sell, or transfer additional shares of common stock, except for certain limited exceptions. This lock-up agreement can provide near-term stability for the stock price.
- Listing: The new shares will be listed on the Nasdaq Global Select Market under the ticker symbol XMTR.
- Legal Compliance: The offering is being made pursuant to the company’s automatic shelf registration statement on Form S-3 (File No. 333-296394), and the legality of the issuance has been confirmed by Cooley LLP, as detailed in their legal opinion attached as Exhibit 5.1.
Potential Impact on Share Price
- Raising \$225 million in growth capital is a major event for Xometry, providing resources for expansion, potential acquisitions, or technology investments. The market’s perception of how these funds will be used could significantly influence the share price.
- Pricing at \$85.00 per share may be viewed as a vote of confidence from both management and institutional investors, but any perceived overhang from new shares may exert short-term pressure on the stock.
- Lock-up period limits insider selling, which could reduce volatility and enhance investor confidence in the months following the offering.
- Disclosure Controls and Financial Health: The company has asserted that it maintains effective disclosure controls and procedures, with no material weaknesses in internal controls reported since the latest audited financial statements. This provides additional assurance regarding the integrity of Xometry’s financial reporting.
- No Written Communications or Soliciting Material: The Form 8-K explicitly states that the filing is not intended to satisfy written communications under Rule 425, soliciting material under Rule 14a-12, or pre-commencement tender offer communications, indicating a routine and compliant capital raising process.
Material Agreements and Legal Opinions
- Underwriting Agreement: Filed as Exhibit 1.1, this agreement details the terms of the share offering and the responsibilities of the underwriters.
- Legal Opinion: Cooley LLP’s opinion (Exhibit 5.1) affirms that the shares, when sold and issued as provided, will be validly issued, fully paid, and nonassessable.
- Consent of Counsel: Also included as part of the filing, confirming the legal standing of the offering.
Key Representations and Warranties
- Xometry represents that its financial statements are prepared in accordance with GAAP and fairly present the company’s financial position.
- The company is not aware of any material adverse changes since the latest reported period that would negatively affect its business, financial position, or ability to perform its obligations under the agreement.
- The company asserts it is not an “investment company” under the Investment Company Act, and has complied with all Sarbanes-Oxley Act requirements.
- There are no pending legal proceedings that are expected to have a material adverse effect on the company.
Implications for Investors
- This capital raise is a pivotal event for Xometry, providing fuel for its next phase of growth. Investors should carefully consider the company’s plans for deploying the proceeds and monitor future announcements regarding acquisitions, product development, or other strategic initiatives.
- The participation of leading investment banks underscores institutional confidence in the deal.
- The share offering and subsequent dilution may create short-term volatility, but long-term value creation will depend on management’s execution of growth initiatives.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should perform their own due diligence and consult with a qualified financial advisor before making investment decisions. The information contained herein is based on public filings and may not reflect the most current developments related to Xometry, Inc.
